STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
32 hedge funds and large institutions have $264M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
+2
Holders Change %
+6.67%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
17
Increased
7
Reduced
3
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.27M |
2 |
BlackRock
New York
|
+$2.04M |
3 |
![]()
Adage Capital Partners
Boston,
Massachusetts
|
+$1.65M |
4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.27M |
5 |
Citadel Advisors
Miami,
Florida
|
+$1.16M |